<DOC>
	<DOCNO>NCT02720536</DOCNO>
	<brief_summary>Extended evaluation deferasirox film-coated tablet ( FCT ) formulation</brief_summary>
	<brief_title>Extended Evaluation Deferasirox Film-coated Tablet ( FCT ) Formulation</brief_title>
	<detailed_description>Collection additional safety efficacy data deferasirox film-coated tablet ( FCT ) patient complete study CICL670F2201 - Provide patient enrol complete 24 week treatment core study , CICL670F2201 , possibility additional treatment deferasirox FCT . - Collect additional long term data safety tolerability deferasirox FCT . - Collect efficacy data deferasirox FCT reduction maintenance iron burden measure serum ferritin level .</detailed_description>
	<mesh_term>Iron Overload</mesh_term>
	<mesh_term>Deferasirox</mesh_term>
	<criteria>Key Inclusion Criteria subject : Completed 24weeks study treatment describe core protocol ( CICL670F2201 ) . Are deem tolerate deferasirox treatment investigator . Provided write informed consent/assent studyspecific procedure perform . For pediatric patient , consent obtain parent ( ) legal patient 's representative . Investigators also obtain assent patient accord local , regional national guideline . Key Exclusion subject : The exclusion criterion follow describe core protocol CICl670F2201 , follow : Creatinine clearance contraindication limit locally approve prescribing information . Serum creatinine &gt; 1.5 × upper limit normal range ( ULN ) Screening Alanine aminotransferase ( ALT ) /serum glutamic pyruvic transaminase ( SGPT ) &gt; 5 × ULN , Significant proteinuria Patients significant impaired gastrointestinal function gastrointestinal disease Clinical laboratory evidence active Hepatitis B Hepatitis C Patients psychiatric addictive disorder</criteria>
	<gender>All</gender>
	<minimum_age>10 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Anemia .</keyword>
	<keyword>Myelodysplastic Syndrome</keyword>
	<keyword>Thalassemia</keyword>
	<keyword>Film coat tablet</keyword>
</DOC>